Loading…
avatar for Alex Sverdlov

Alex Sverdlov

Novartis, United States
Senior Director, Biostatistics
Alex Sverdlov has worked as a statistical scientist in the biopharmaceutical industry since 2007. He is currently neuroscience disease area lead statistician in early clinical development at Novartis. Alex has been involved in active research on adaptive designs for clinical trials to improve efficiency of drug development. He is the editor of a monograph “Modern Adaptive Randomized Clinical Trials: Statistical and Practical Aspects” (2015, CRC Press) and a co-author of a book “Mathematical and Statistical Skills in the Biopharmaceutical Industry: A Pragmatic Approach” (2019, CRC Press).
  • Timezone
  • Filter By Date DIA 2022 Global Annual Meeting Jun 13 -23, 2022
    • June 2022
      SunMonTueWedThuFriSat
       1234
      567891011
      12131415161718
      19202122232425
      2627282930 
  • Filter By Venue Chicago, IL, USA
  • Filter By Type
  • 00: Plenary
  • 01: ClinSafety-PV
  • 02: ClinTrials -ClinOps
  • 03: Data-Tech in Clinical Trials
  • 04: MedAffairs-SciComm
  • 05: Patient Engagement
  • 06: PreClinical Dev-EarlyPhaseCR
  • 07: ProjectManagement-StrategicPlanning
  • 08: RD Quality-Compliance
  • 09: Regulatory
  • 10: RegCMC-Product Quality
  • 11: Statistics
  • 12: Value-Access
  • 13: ProfDevelopment
  • 14: DIAmond
  • 15: Content Hubs
  • 16: Community Rounds
  • 17: Networking Opportunities
  • 18: Posters
  • 19: InnovationTheaters
  • 20: Short Courses
  • Level
  • Featured Topics